Search Browse Earnings

Vyome Holdings, Inc

Nasdaq:HIND

Pharmaceutical Preparations·SAN CLEMENTE, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Nelabhotla Venkateswarlu

CFO

Dickey Robert Iv

Revenue

$8.7M

-22.8% YoY

FY 2024

Adj. EBITDA

-$14.9M

-171.7% margin

FY 2024

Net Income

-$11.4M

-131.2% margin

FY 2024

EPS (Diluted)

-$110.87

FY 2024

Stock Price

$2.61

-5.4%

2026-03-10

52W Range

$1.75 – $305.00

P/E Ratio

-0.0x

Market Cap

$14.7M

Cash

$4.5M

FY 2024

Total Debt

$10.0M

FY 2021

Net Debt

$5.5M

FY 2021

Enterprise Value

$20.3M

Debt / EBITDA

-0.4x

FY 2024

EV / EBITDA

-1.4x

Employees

2

FY 2024